Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
  • Biotech Companies
    • Biotech Crowdfunding
    • Biotech Investors
    • Biotech Companies
    • Biotech companies Database
  • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News
  • Offers
  • Contact

Tag Archives: APIs

Biomay – recombinant allergens

Posted on 2015-05-20 by Biotech365

Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.

Biomay – recombinant allergens

biomay Continue reading →

Posted in Biotech Companies, Biotech Companies Austria | Tagged Active Pharmaceutical Ingredients, allergen, allergen-specific immunotherapy, allergens, allergic, allergic patients, allergy, allergy therapeutics, Angela Neubauer, antihistamine, antihistamines, API, APIs, Biomay, Biomay - recombinant allergens, birch pollen allergies, birch pollen allergy, BM31, BM32, grass pollen allergies, grass pollen allergy, Hans Huber, Hans Ulrich Wahn, IgE, IgG, Karl Fister, Marek Jutel, Marianne van Hage, peptide carrier fusion vaccine, peptide carrier fusion vaccines, Peter Creticos, pharmacotherapy, Rainer Henning, recombinant allergen, recombinant allergens, SIT, Stephen Durham, therapeutics

Follow Biotech 365 !

Follow @Biotech365

Newsletter

Search on Biotech 365 :

Search for Protocols :

Search on PubMed :

                      About us                       Terms                       Partners                       Contact                       Offers                       RSS feed - Biotech 365                      
Proudly powered by WordPress